Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Novartis India...

    Novartis India Managing Director Milan Paleja quits

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-12-06T10:05:29+05:30  |  Updated On 6 Dec 2018 10:05 AM IST
    Novartis India Managing Director Milan Paleja quits

    New Delhi: Pharmaceutical major Novartis India recently announced that its Managing Director and Chairman, Milan Paleja has decided to resign from the post with effect from May 31, 2019.


    The company informed through a regulatory filing to the BSE that Paleja has decided to abdicate from the post in order to embrace challenges outside of Novartis.


    The Board has requested the Nomination & Remuneration Committee to identify and recommend a suitable successor for the role of Managing Director of the Company.


    Milan Paleja joined the company in the month of June 2018. Alumni of Harvard Business school Paleja served the company for seven months.


    Paleja had been appointed after the previous Novartis Vice-Chairman and MD, Jawed Zia decided to step down mid-March, within days of his taking charge. Zia had been appointed in January to take charge from Ranjit Shahani who was leaving the company on February 28, 2018.


    Paleja turned around the business and laid the foundation for future magnification. During his tenure in Indonesia, he initiated innovative access models. He enjoyed the position of Country President and Head Pharmaceuticals in Novartis Indonesia since March 2016. During his early incumbency in Novartis India, he was also appointed as Country President.

    Milan is a graduate from Bombay University and holds a Cost Accountants degree from the Institute of Cost Accountants of India.


    In his tenure at Novartis, he worked and lead in multiple geographies including Asia, Middle East & Africa at Country, Cluster & Regional Level.


    Also Read: After 12 years of service, Lupin Chief Financial Officer quits to pursue non-pharma opportunities

    Drug firmHarvardIndiaJawedManaging directorMilan PalejahasNovartispharmaceuticalremunerationzia
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok